https://imi-premier.eu/wp-content/uploads/2025/05/Copia-de-Meet-the-SAB-Despo-Fatta-Kassinos-2000-×-1080-px.png
675
1200
Marta Álvarez
https://imi-premier.eu/wp-content/uploads/2020/11/logo-imi-premier.png
Marta Álvarez2025-05-14 14:22:402025-05-22 11:28:29Meet our Scientific Advisory Board: interview with Reinhard Laenge
New scientific paper: Read-across of biotransformation potential between activated sludge and the terrestrial environment: Toward making it practical and plausible
General
New scientific paper: A database on pharmaceuticals in the environment: What do stakeholders need?
General
Driving Innovation for Environmental Safety: PREMIER’s 9th General Assembly in Bilthoven advances novel assessment systems for medicine risks with limited data
General
https://imi-premier.eu/wp-content/uploads/2024/12/Red-Simple-Illustration-Minimalist-Brainstorming-Presentation.png
1080
1920
Marta Álvarez
https://imi-premier.eu/wp-content/uploads/2020/11/logo-imi-premier.png
Marta Álvarez2024-12-11 10:57:582024-12-11 10:57:58Highlights from PREMIER’s engagement with DG SANTE
https://imi-premier.eu/wp-content/uploads/2024/12/Meet-the-SAB.png
675
1200
Marta Álvarez
https://imi-premier.eu/wp-content/uploads/2020/11/logo-imi-premier.png
Marta Álvarez2024-12-11 10:56:382024-12-17 12:55:12Meet our Scientific Advisory Board: interview with Fiona Polack
New scientific paper: Prioritisation of data-poor pharmaceuticals for empirical testing and environmental risk assessment
General
New scientific paper: Many human pharmaceuticals are weak inhibitors of the cytochrome P450 system in rainbow trout (Oncorhynchus mykiss) liver S9 fractions
General
New scientific paper: Design of greener drugs: aligning parameters in pharmaceutical R&D and drivers for environmental impact
General



